Effect of ulinastatin combined with Xuebijing injection in treatment of post-cardiac arrest syndrome:a clinical analysis

Clinical Focus ›› 2015, Vol. 30 ›› Issue (9): 988-992.

Previous Articles Next Articles

Effect of ulinastatin combined with Xuebijing injection in treatment of post-cardiac arrest syndrome:a clinical analysis

Zhang Jing;Liu Zhongmin

Online:2015-09-05 Published:2015-09-05

Abstract

CLC Number:

R541.78

Zhang Jing;Liu Zhongmin. Effect of ulinastatin combined with Xuebijing injection in treatment of post-cardiac arrest syndrome:a clinical analysis[J]. Clinical Focus, 2015, 30(9): 988-992.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2015/V30/I9/988

[1]	Gao Weikang, Quan Jianhua, Niu Xinrong. One case of missed diagnosis of multiple organ dysfunction syndrome complicated with adrenal crisis and literature review [J]. Clinical Focus, 2023, 38(4): 356-358.
[2]	Liu Peihua, Yang Qian, Liu Zhiqiang, Liang Lu. Continuous veno-venous hemodiafiltration plus activated charcoal hemoperfusion in treatment of multiple organ dysfunction syndrome caused by fish bile poisoning: one case [J]. Clinical Focus, 2022, 37(8): 738-742.
[3]	Sun Zhonghua, Xu Chi, Wang Yue, Liu Lijie, Li Bangbang, Liu Xuejuan. Metaanalysis of the application of Xuebijing injection as an adjuvant in the western routine treatment of severe communityacquired pneumonia [J]. Clinical Focus, 2020, 35(10): 869-875.
[4]	Zhang Yanwei, Zhao Mailiang, Zhang Sheng, Zhou Kuilong, Gao Hui, Wang Junhui, Zhao Xing, Li Chao. Effect of Xuebijing injection combined with ulinastatin on sepsis induced ARDS patients [J]. Clinical Focus, 2018, 33(7): 575-578.
[5]	Li Yongsheng1， Ma Xiaofeng2. Protective effect of ulinastatin on intestinal epithelial cell barrier [J]. Clinical Focus, 2017, 32(11): 953-956.
[6]	. Influence of ulinastatin on lung permeability after liver transplantation [J]. Clinical Focus, 2015, 30(7): 814-817.
[7]	Yan Xiuzong;Shao Dongfeng;Yang Liyuan. Clinical analysis of low molecular weight heparin combined with ulinastatin in treatment of severe acute pancreatitis [J]. Clinical Focus, 2015, 30(7): 799-802.
[8]	Sun Long;Cai Duxiong. Cystatin-C level in acute pancreatitis leading to systemic inflammatory response syndrome resulted multiple organ dysfunction syndrome patients [J]. Clinical Focus, 2015, 30(5): 532-535.
[9]	Tian Huiyu;Jiang Xiangming;Song Shaohua;Zhang Jie;Lu Peng;Jin Yujie;Yang Xiufen. Relationship between permissible dose of heparin and severity of illness and prognosis in patients with multiple organ dysfunction syndrome during continuous veno-venous hemofiltration [J]. Clinical Focus, 2015, 30(1): 67-70.
[10]	PENG Huan-qing;PENG Zhi-yun;FAN Zhi-yong;TANG Zhong-xiang;LIN Hui-wen;LI Feng-hui;WANG Ying-jing. Influence of ulinastatin on von Willebrand factor and thrombomodulin in patients with sepsis [J]. Clinical Focus, 2014, 29(9): 1012-1.0141e+007.
[11]	HU Jie-yu;QIN Hua;CHEN Zhao-yan;ZHAO Xiao-qin. Clinical analysis on 166 cases with acute respiratory distress syndrome of pulmonary origin and extra-pulmonary origin [J]. CLINICAL FOCUS, 2014, 29(3): 298-301.

Effect of ulinastatin combined with Xuebijing injection in treatment of post-cardiac arrest syndrome:a clinical analysis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 11

Recommended Articles

Metrics

Comments